CCCC Shares Outstanding History
Below is a table of the CCCC shares outstanding history going back to 10/2/2020:

Date CCCC Shares Outstanding
10/2/202040.77M
11/10/202043.03M
3/1/202143.12M
5/3/202143.20M
8/2/202148.45M
11/1/202148.63M
2/15/202248.74M
4/25/202248.80M
7/27/202248.91M
10/26/202248.96M

Also see: CCCC Market Cap History
CCCC YTD Return
CCCC Historical Shares Outstanding:
+9.26% CAGR
CCCC Historical Shares Outstanding: +9.26% CAGR

Mouse over chart for data details
10/2/2020 ...10/26/2022
C4 Therapeutics is a biopharmaceutical company engaged in the development of novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Co.'s primary product candidate is CFT7455, an orally bioavailable degrader targeting IKZF1/3 for multiple myeloma, peripheral T-cell lymphoma, and mantle cell lymphoma. Co. is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid malignancies; and BRAF V600E and RET programs for genetically defined resistant solid tumors. We show 10 historical shares outstanding datapoints in our coverage of CCCC's shares outstanding history.

Understanding the changing numbers of CCCC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CCCC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CCCC by allowing them to research CCCC shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CCCC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
C4 Therapeutics (CCCC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CCEL Shares Outstanding History
CCRN Shares Outstanding History
CCXI Shares Outstanding History
CDAK Shares Outstanding History
CDMO Shares Outstanding History
CDNA Shares Outstanding History
CDRE Shares Outstanding History
CDTX Shares Outstanding History
CDXC Shares Outstanding History
CELC Shares Outstanding History
More Healthcare companies »

 

CCCC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.